Skip to main content
Clinical Trials/NCT02570763
NCT02570763
Withdrawn
N/A

Combining Non-Invasive Brain Stimulation With Cognitive Behavioral Intervention in Substance Use Disorder

University of Minnesota0 sitesNovember 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Active tDCS
Sponsor
University of Minnesota
Primary Endpoint
Therapy Content Memory Assessment
Status
Withdrawn
Last Updated
8 years ago

Overview

Brief Summary

The current study aims to examine the safety and feasibility of utilizing tDCS to enhance affect-laden episodic memory consolidation among adults with co-occurring alcohol use and anxiety disorders who have recently undergone detoxification as a step toward the translational clinical application of this approach.

Registry
clinicaltrials.gov
Start Date
November 2015
End Date
July 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • DSM IV diagnosis of panic disorder (with or without agoraphobia), generalized anxiety disorder, or social anxiety disorder within the past 30 days
  • DSM IV diagnosis of alcohol dependence within the last 30 days
  • inpatient treatment at Lodging Plus primarily for alcohol (vs. other drug) dependence
  • alcohol use in the 30 days preceding the study
  • willingness to provide informed consent
  • minimum of a sixth grade English reading level (deemed necessary to complete study materials); as determined by their being able to read and understand the consent form.
  • Living within reasonable driving distance (1 hour or less) of the Twin Cities to allow for in-person follow-up interviews

Exclusion Criteria

  • lifetime history of psychosis or mania by history.
  • cognitive (e.g., dementia) or physical impairment (e.g., blindness) that interferes with study participation report or as judged by PI/study physician.
  • Current suicide risk as deemed by the PI and study physician to be serious and ongoing
  • any medical condition or treatment with neurological sequelae (e.g., stroke, tumor, loss of consciousness of more than 30 minutes, HIV, seizures)
  • history of ECT
  • document loss of consciousness (LOC) for longer than 30 minutes or LOC with neurological sequelae
  • pregnancy
  • Although seizures are not a known risk of tDCS intervention (Fregni et al., 2006; Nitsche et al., 2008), anyone with a history or a risk for seizures will be excluded from the study
  • anyone with metal objects implanted in their head or neck
  • anyone taking stimulant medications for any reason as we wish to avoid two sorces of neurostimulation

Outcomes

Primary Outcomes

Therapy Content Memory Assessment

Time Frame: 24 hours

Participant's will complete daily assessments of their memory for therapy content from the previous session.

Similar Trials